Patheon API Seeks DEA Registration for Research-Related Manufacturing
February 15, 2025
February 15, 2025
WASHINGTON, Feb. 15 (TNSFR) -- The Drug Enforcement Administration has announced that Patheon API Inc. has applied for registration to manufacture certain pharmaceutical compounds at its facility in Florence, South Carolina.
The company intends to import and produce specific substances as reference standards for research and development within its active pharmaceutical ingredient (API) manufacturing operations. This application follows federal guidelines governing the handling of s . . .
The company intends to import and produce specific substances as reference standards for research and development within its active pharmaceutical ingredient (API) manufacturing operations. This application follows federal guidelines governing the handling of s . . .